, thanks Unilever and the European Research Commission (Starting Grant ERC-2013- StG 336159 MIXTURE) for funding, M.N. thanks the Investissement d'Avenir Bioinformatics Program (Grant Bip:Bip) and the European Research Commission (Advanced Grant ERC-2011-StG 294809 BayCellS) for funding. Conflict of Interest: none declared
, The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology, Cancer Research, vol.73, issue.14, pp.4372-4382, 2013.
DOI : 10.1158/0008-5472.CAN-12-3342
, Development of the Proteasome Inhibitor Velcade??? (Bortezomib), Cancer Investigation, vol.98, issue.11, pp.304-311, 2004.
DOI : 10.1016/S0093-7754(01)90034-X
, Integrative and Personalized QSAR Analysis in Cancer by Kernelized Bayesian Matrix Factorization, Journal of Chemical Information and Modeling, vol.54, issue.8, pp.2347-2359, 2014.
DOI : 10.1021/ci500152b
, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, vol.53, issue.7391, pp.603-607, 2012.
DOI : 10.1002/pbc.20697
, Molecular similarity searching using atom environments , information-based feature selection, and a Na?¨veNa?¨ve Bayesian classifier, 2004.
, How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space, Journal of Chemical Information and Modeling, vol.49, issue.1, pp.108-119, 2009.
DOI : 10.1021/ci800249s
, How accurate are cancer cell lines?, Nature, vol.463, issue.7283, pp.463-858, 2010.
DOI : 10.1038/nature08822
, Functional Motions Modulating VanA Ligand Binding Unraveled by Self-Organizing Maps, Journal of Chemical Information and Modeling, vol.54, issue.1, pp.289-301, 2014.
DOI : 10.1021/ci400354b
, Random forests, Machine Learning, vol.45, issue.1, pp.5-32, 2001.
DOI : 10.1023/A:1010933404324
, Computational chemogenomics: Is it more than inductive transfer?, Journal of Computer-Aided Molecular Design, vol.2, issue.1, pp.597-618, 2014.
DOI : 10.1007/s10822-014-9743-1
, Statistical variation in progressive scrambling, Journal of Computer-Aided Molecular Design, vol.7, issue.7-9, pp.563-576, 2004.
DOI : 10.1007/s10822-004-4077-z
, Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling, Journal of Cheminformatics, vol.7, issue.1, 2014.
DOI : 10.1093/bioinformatics/btn479
URL : https://hal.archives-ouvertes.fr/pasteur-01398459
, Comparing the Influence of Simulated Experimental Errors on 12 Machine Learning Algorithms in Bioactivity Modeling Using 12 Diverse Data Sets, Journal of Chemical Information and Modeling, vol.55, issue.7, pp.1413-1425, 2015.
DOI : 10.1021/acs.jcim.5b00101
, Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects, Med. Chem. Commun., vol.503, issue.suppl. 1, p.24, 2015.
DOI : 10.1093/bib/bbu010
, Temperature Accelerated Molecular Dynamics with Soft-Ratcheting Criterion Orients Enhanced Sampling by Low-Resolution Information, Journal of Chemical Theory and Computation, vol.11, issue.7, pp.3446-3454, 2015.
DOI : 10.1021/acs.jctc.5b00153
URL : https://hal.archives-ouvertes.fr/pasteur-01300945
, A community effort to assess and improve drug sensitivity prediction algorithms, Nature Biotechnology, vol.33, issue.12, pp.1202-1212, 2014.
DOI : 10.1093/jnci/83.11.757
URL : https://hal.archives-ouvertes.fr/hal-01101874
, Structure-Based Identification of OATP1B1/3 Inhibitors, Molecular Pharmacology, vol.83, issue.6, pp.1257-1267, 2013.
DOI : 10.1124/mol.112.084152
, Metrics other than potency reveal systematic variation in responses to cancer drugs, Nature Chemical Biology, vol.6, issue.11, pp.708-714, 2013.
DOI : 10.1038/nmeth.1600
, Systematic identification of genomic markers of drug sensitivity in cancer cells, Nature, vol.58, issue.7391, pp.570-575, 2012.
DOI : 10.1101/gr.1239303
, Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines, Genome Biology, vol.15, issue.3, p.47, 2014.
DOI : 10.1002/gepi.21750
, Global Proteome Analysis of the NCI-60 Cell Line Panel, Cell Reports, vol.4, issue.3, pp.609-620, 2014.
DOI : 10.1016/j.celrep.2013.07.018
, Beware of q2!, Journal of Molecular Graphics and Modelling, vol.20, issue.4, pp.269-276, 2002.
DOI : 10.1016/S1093-3263(01)00123-1
, Inconsistency in large pharmacogenomic studies, Nature, vol.85, issue.7480, pp.389-93, 2013.
DOI : 10.1038/75556
, Protein-ligand interaction prediction: an improved chemogenomics approach, Bioinformatics, vol.24, issue.19, pp.2149-2156, 2008.
DOI : 10.1093/bioinformatics/btn409
URL : https://hal.archives-ouvertes.fr/hal-00433572
, Virtual screening of GPCRs: An in silico chemogenomics approach, BMC Bioinformatics, vol.9, issue.1, p.363, 2008.
DOI : 10.1186/1471-2105-9-363
URL : https://hal.archives-ouvertes.fr/hal-00220396
, SYSTEMATIC ASSESSMENT OF ANALYTICAL METHODS FOR DRUG SENSITIVITY PREDICTION FROM CANCER CELL LINE DATA, Biocomputing 2014, pp.63-74, 2014.
DOI : 10.1142/9789814583220_0007
, How Diverse Are Diversity Assessment Methods? A Comparative Analysis and Benchmarking of Molecular Descriptor Space, Journal of Chemical Information and Modeling, vol.54, issue.1, pp.230-242, 2013.
DOI : 10.1021/ci400469u
, A modular approach for integrative analysis of large-scale gene-expression and drug-response data, Nature Biotechnology, vol.7, issue.5, pp.531-539, 2008.
DOI : 10.1038/nbt1397
, Molecular signatures database (MSigDB) 3.0, Bioinformatics, vol.27, issue.12, pp.1739-1740, 2011.
DOI : 10.1093/bioinformatics/btr260
, DNA fingerprinting of the NCI-60 cell line panel, Molecular Cancer Therapeutics, vol.8, issue.4, pp.713-724, 2009.
DOI : 10.1158/1535-7163.MCT-08-0921
, Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties, PLoS ONE, vol.2, issue.3, 2013.
DOI : 10.1371/journal.pone.0061318.s007
, Chemically Aware Model Builder (camb): an R package for property and bioactivity modelling of small molecules, Journal of Cheminformatics, vol.8, issue.1, p.45, 2015.
DOI : 10.1186/s13321-015-0086-2
URL : https://hal.archives-ouvertes.fr/pasteur-01399284
, Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays, Proceedings of the National Academy of Sciences, vol.100, issue.24, pp.14229-14234, 2003.
DOI : 10.1073/pnas.2331323100
, Introducing Conformal Prediction in Predictive Modeling. A Transparent and Flexible Alternative to Applicability Domain Determination, Journal of Chemical Information and Modeling, vol.54, issue.6, pp.1596-1603, 2014.
DOI : 10.1021/ci5001168
, Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm, JNCI Journal of the National Cancer Institute, vol.81, issue.14, pp.1088-1092, 1989.
DOI : 10.1093/jnci/81.14.1088
, Scikit-learn: machine learning in python, J. Mach. Learn. Res, vol.12, pp.2825-2830, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00650905
, Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron, Cancer Research, vol.70, issue.6, pp.2191-2203, 2010.
DOI : 10.1158/0008-5472.CAN-09-3528
, CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set, Cancer Research, vol.72, issue.14, pp.3499-3511, 2012.
DOI : 10.1158/0008-5472.CAN-12-1370
, Predicting in vitro drug sensitivity using Random Forests, Bioinformatics, vol.27, issue.2, pp.220-224, 2011.
DOI : 10.1093/bioinformatics/btq628
, Using Random Forest To Model the Domain Applicability of Another Random Forest Model, Journal of Chemical Information and Modeling, vol.53, issue.11, pp.2837-2850, 2013.
DOI : 10.1021/ci400482e
, Structural similarity assessment for drug sensitivity prediction in cancer, BMC Bioinformatics, vol.10, issue.Suppl 9, pp.17-24, 2009.
DOI : 10.1186/1471-2105-10-S9-S17
, The NCI60 human tumour cell line anticancer drug screen, Nature Reviews Cancer, vol.98, issue.10, pp.813-823, 2006.
DOI : 10.1038/nrc1951
, Chemosensitivity prediction by transcriptional profiling, Proceedings of the National Academy of Sciences, vol.98, issue.19, pp.10787-92, 2001.
DOI : 10.1073/pnas.191368598
, Structured Output Prediction of Anti-cancer Drug Activity, Pattern Recognition in Bioinformatics, pp.38-49, 2010.
DOI : 10.1007/978-3-642-16001-1_4
, Predicting drug sensitivity and resistance, Cancer Cell, vol.6, issue.2, pp.129-137, 2004.
DOI : 10.1016/j.ccr.2004.06.026
, Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets, Med. Chem. Commun., vol.48, issue.1, pp.16-30, 2011.
DOI : 10.1039/C0MD00165A
, High Resolution Copy Number Variation Data in the NCI-60 Cancer Cell Lines from Whole Genome Microarrays Accessible through CellMiner, PLoS ONE, vol.32, issue.3, p.92047, 2014.
DOI : 10.1371/journal.pone.0092047.s005
, An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge, PLoS ONE, vol.2, issue.6, p.101183, 2014.
DOI : 10.1371/journal.pone.0101183.s003
, Drug discovery: Cell lines battle cancer, Nature, vol.464, issue.7391, pp.544-545, 2012.
DOI : 10.1038/nature07385
, Neural computing in cancer drug development: predicting mechanism of action, Science, vol.258, issue.5081, pp.447-451, 1992.
DOI : 10.1126/science.1411538
, An Information-Intensive Approach to the Molecular Pharmacology of Cancer, Science, vol.275, issue.5298, pp.343-349, 1997.
DOI : 10.1126/science.275.5298.343
, Cancer pharmacogenomics: strategies and challenges, Nature Reviews Genetics, vol.99, issue.1, pp.23-34, 2013.
DOI : 10.1038/nrg3352
, Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework, Bioinformatics, vol.26, issue.12, pp.246-254, 2010.
DOI : 10.1093/bioinformatics/btq176